// App-Quantinova.ai

5076 : Germline variant alleles in rs12422149 of SLCO2B1 and response to abiraterone acetate (AA) in men with metastatic castration-resistant prostate cancer (mCRPC).

Researchers

Presenter

  • Andrew W Hahn

Principal Investigators

  • David Michael Gill

  • Peter Hale

  • Austin Poole

  • Roberto Nussenzveig

  • Sara Wilson

  • James M. Farnham

  • Robert A Stephenson

  • Benjamin Louis Maughan

  • Lisa Cannon-Albright

  • Neeraj Agarwal

Medical Centers

  • University of Utah-Huntsman Cancer Institute, Salt Lake City, UT

  • University of Utah-Huntsman Cancer Institute, Salt Lake City, UT

  • University of Utah-Huntsman Cancer Institute, Salt Lake City, UT

  • Hunstman Cancer Institute of Utah, Salt Lake City, UT

  • University of Utah, Salt Lake City, UT

  • Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT

  • Hunstman Cancer Institute of Utah, Salt Lake City, UT

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • CB-7598

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved